1. History
Single ventricle or double inlet ventricle (DIV) is a congenital heart malformation in which both atrioventricular valves (or a single common atrioventricular valve) connect to one ventricle; it was first described anatomically by Holmes in 1932. Before the 1970s there was no surgical treatment, and most patients died in infancy. In 1971, Fontan and Baudet of France first successfully performed a direct right atrium–pulmonary artery anastomosis in tricuspid atresia, establishing the principle of passive pulmonary circulation (Fontan circulation), in which the pulmonary circulation is maintained without a ventricular pump. This procedure was subsequently extended as a concept applied to all complex congenital heart malformations with single-ventricle anatomy. In 1988, de Leval et al. developed the total cavopulmonary connection (TCPC), establishing a more physiological blood flow pathway that bypasses the right atrium. In the 1980s, Norwood systematized a staged palliative surgical approach for hypoplastic left heart syndrome—Norwood stage 1, bidirectional Glenn (superior vena cava–pulmonary artery connection), and Fontan stage 3. Today this three-stage strategy has become the standard treatment framework for all congenital heart malformations with single-ventricle anatomy.
2. Causes
Single ventricle/double inlet ventricle is the final anatomical phenotype of heterogeneous complex congenital heart malformations arising from various genetic and environmental causes. Various anatomical subtypes such as hypoplastic left heart syndrome (HLHS, about 25%), tricuspid atresia (about 20–25%) and univentricular atrioventricular connection (double inlet left ventricle, DILV) fall into the "functional single ventricle" category. The genetic cause of DILV itself has not yet been clearly identified, and most cases occur sporadically. Known genetic associations include Noonan syndrome (PTPN11, RAF1, SOS1 variants), Kabuki syndrome (KMT2D variants), CHARGE syndrome (CHD7 variants), 22q11.2 deletion and Turner syndrome. Abnormalities of the Notch signaling pathway (NOTCH1, JAG1 variants) cause left heart underdevelopment and are associated with HLHS. Environmental risk factors include diabetes in early pregnancy, maternal phenylketonuria, lithium (increased risk of congenital heart malformation) and retinoic acid exposure. Familial recurrence is rare, but the sibling recurrence risk is higher than in the general population.
3. Genetics
The genetic basis of functional single ventricle/double inlet ventricle differs by anatomical subtype. In single ventricle associated with HLHS, heterozygous loss-of-function variants of NOTCH1 (9q34.3) and variants of GJA1 (connexin 43) and ELN (elastin) have been reported. HAND1 (4q33) variants cause left ventricular underdevelopment in mice, and their association with human HLHS is being studied. In single ventricle associated with tricuspid atresia, NOTCH2 and JAG1 variants are understood to cause abnormalities of the right ventricular inlet. Whole-exome sequencing (WES) studies have identified variants in genes related to lymphatic and vascular development, such as CHD7, FLT4, VEGFC and KDR, in patients with functional single ventricle. Among chromosomal abnormalities, aortic stenosis and HLHS accompany Turner syndrome (45,X), and 22q11.2 deletion, 8p23.1 deletion and others are associated with complex heart malformations. Clinically, when single ventricle is diagnosed, chromosomal microarray and a syndrome-specific gene panel or WES are recommended.
4. General epidemiology
Functional single ventricle (including all anatomical subtypes) is estimated at about 2–3 per 10,000 live births. Restricted to simple double inlet left ventricle (DILV), it is about 0.5–1 per 10,000. In Korea, based on Health Insurance Review & Assessment Service (HIRA) data, about 80–120 new diagnoses of single ventricle–related malformations (including HLHS) are reported annually. Hypoplastic left heart syndrome (HLHS) is the most common of the single-ventricle group, accounting for about 20–25% of all single ventricles. Sex differences vary by anatomical subtype but are overall slightly higher in boys. When associated with asplenia/polysplenia (heterotaxy syndrome), complex single-ventricle anatomy is frequent. The prenatal detection rate is high in HLHS at about 60–80% but relatively low in other subtypes. Because it is a high-risk malformation, systematic pre-delivery planning and transfer to a tertiary care center are essential when diagnosed prenatally.
5. Pathophysiology
The heart begins to develop at the end of the third week of embryonic development when two endocardial tubes originating from the lateral plate mesoderm fuse in the midline to form a single heart tube. The heart tube then loops to the right (rightward looping, D-looping) so that the atria, ventricles and outflow tract are arranged in sequence, and outflow tract septation, valve formation and separation of the great vessels are completed through neural crest cell migration and the influx of second heart field (SHF) cells. Transcription factors regulating this process include NKX2-5, GATA4, TBX1, TBX5, HAND1/2 and ISL1, and variants in these genes or environmental disruption constitute the common pathogenetic mechanism of congenital heart malformations.
Double inlet ventricle (DIV) results from failure of lateralization of the atrioventricular canal or regression of one atrioventricular connection. In normal development the atrioventricular canal divides evenly to the left and right and connects to each ventricle, but in DIV the atrioventricular canal does not divide, so both atria connect to one dominant ventricle. In DILV (double inlet left ventricle), the morphological left ventricle is the dominant ventricle, and a small right ventricle (outlet chamber) remains as the non-dominant ventricle, giving rise to the aorta or pulmonary artery. DIRV (double inlet right ventricle), in which the dominant ventricle is a morphological right ventricle, is much rarer. In HLHS, early underdevelopment of the mitral valve/aorta limits blood flow to the left ventricle, and the resulting left ventricular undergrowth leads to single-ventricle anatomy—the flow-dependent growth model is the key pathogenetic mechanism. In tricuspid atresia, the tricuspid valve does not develop, blocking normal inflow to the right ventricle, and the right ventricle is hypoplastic.
6. Symptoms
The symptoms of single ventricle span a very wide spectrum depending on the anatomical subtype and how pulmonary blood flow is regulated. In the unobstructed pulmonary blood flow type, congestive heart failure due to excessive pulmonary blood flow is the main symptom: tachypnea, poor feeding, diaphoresis and failure to thrive appear in infancy within a few weeks. In the obstructed pulmonary blood flow type (e.g., pulmonary stenosis), central cyanosis is the main symptom from the neonatal period. In HLHS, shock due to obstruction of the systemic outflow (predisposing: pallor, lethargy, weak pulses, metabolic acidosis) develops abruptly within hours to days after birth, and death is immediate unless ductal patency is maintained. In tricuspid atresia, the degree of cyanosis depends on the amount of pulmonary blood flow; without pulmonary stenosis heart failure predominates, and with stenosis cyanosis predominates. Failure to thrive, recurrent respiratory infections and reduced exercise tolerance are common.
7. Signs
On physical examination, signs of cyanosis or heart failure predominate. In neonates with HLHS, when the ductus arteriosus begins to constrict, the triad of absent peripheral pulses, cyanosis and decreased consciousness appears, a serious condition. Heart murmurs vary with associated anomalies (VSD, pulmonary stenosis), and in isolated HLHS there is no murmur or it is nonspecific. The second heart sound is heard as single and accentuated. The electrocardiogram shows right ventricular hypertrophy (small right ventricle in DILV), left ventricular hypertrophy (DIRV), or nonspecific changes. Chest X-ray shows cardiomegaly and changes in pulmonary vascular markings (increased or decreased). Echocardiography shows both atrioventricular valves connecting to one dominant ventricle, absence or poor development of the ventricular septum, and abnormal arrangement of the great vessels. Oxygen responsiveness testing (induced hyperventilation or 100% oxygen administration) is used to assess pulmonary vascular resistance.
8. Screening
Prenatal screening is performed by detailed fetal echocardiography at 18–22 weeks of gestation. Marked imbalance in the size of the two ventricles, unilateralization of the atrioventricular valve, or absence of the ventricular septum on the four-chamber view are the key findings suggesting single ventricle. HLHS is characterized on the four-chamber view by right heart dominance, a diminutive left heart and a small mitral valve and aorta, and its prenatal detection rate is high. When diagnosed prenatally, delivery planning, preparation for neonatal emergency care and parental counseling should proceed immediately. After birth, neonatal congenital heart disease screening (pulse oximetry) contributes to detecting cyanotic single ventricle, but caution is needed because SpO₂ may initially be within the normal range in HLHS with excessive pulmonary blood flow. Auscultation for murmurs, palpation of peripheral pulses and assessment of systemic perfusion are important in neonatal examinations. In HLHS, immediate administration of PGE1 after birth is the top-priority measure to maintain ductal patency.
9. Diagnosis
Systematic multimodal imaging evaluation is essential for accurate anatomical diagnosis and surgical planning in single ventricle. Echocardiography is the primary diagnostic tool, applying Anderson's segmental analysis to describe atrial arrangement, atrioventricular connections, ventricular morphology and great vessel connections. It assesses whether the dominant ventricle is a morphological left or right ventricle (DILV vs DIRV), whether the atrioventricular valve is common and its function, the outflow direction of the non-dominant ventricle, the arrangement of the great vessels, the location and size of the ventricular septum, and the presence of pulmonary/aortic stenosis. Cardiac CT angiography is used to identify three-dimensional vascular anatomy, anomalous caval connections (such as bilateral superior vena cava) and anomalous pulmonary venous return. Cardiac MRI is excellent for quantifying ventricular volumes, myocardial characterization and hemodynamic assessment after the Fontan operation. Cardiac catheterization is essential for measuring pulmonary vascular resistance (PVR) and assessing pressures before and after Glenn and before Fontan; when PVR is >4 Wood units/m² or mean pulmonary artery pressure is >15 mmHg, Fontan candidacy becomes questionable. Chromosomal microarray and WES are applied to exclude associated syndromes and for genetic counseling.
10. Treatment
Because complete repair of single ventricle is not possible, the standard is a three-stage palliative surgical pathway aimed at establishing Fontan circulation.
Stage 1: neonatal palliative surgery (age 1–2 weeks)
Excessive pulmonary blood flow type (including HLHS): the Norwood procedure (pulmonary artery–aorta anastomosis + aortic reconstruction + modified BTS or Sano right ventricle–pulmonary artery conduit) creates a single-ventricle parallel circulation in which the single ventricle supplies both the systemic and pulmonary circulations. Excessive pulmonary blood flow type in general: pulmonary artery banding (PA banding) to restrict pulmonary blood flow and protect the pulmonary vasculature. Insufficient pulmonary blood flow type: systemic-to-pulmonary shunt (BTS) to augment pulmonary blood flow.
Stage 2: bidirectional Glenn operation (age 3–6 months)
The superior vena cava (SVC) is anastomosed directly to the right pulmonary artery so that venous blood from the upper body flows directly to the lungs without passing through the ventricle. It is performed once pulmonary vascular resistance is low and some growth has been achieved.
Stage 3: Fontan operation (age 2–4 years)
The inferior vena cava (IVC) is also connected to the pulmonary artery (total cavopulmonary connection, TCPC) to complete the Fontan circulation, in which all systemic venous blood is oxygenated through the lungs and then returns to the single ventricle. The extracardiac conduit or lateral tunnel technique is mainly used. A Fontan fenestration is created to aid early physiological adaptation.
Postoperative management: anticoagulation (aspirin or warfarin), diuretics, ACE inhibitors, regular echocardiography and MRI follow-up, and continued surveillance for Fontan complications such as protein-losing enteropathy, liver fibrosis and arrhythmias. Transition to adult care (GUCH) is central to managing long-term Fontan-related complications.
11. Prognosis
Long-term survival of patients with single ventricle after the modern three-stage Fontan operation has improved greatly compared with the past but remains markedly lower than in the general population. In a 40-year follow-up study from the Mayo Clinic (Pundi et al., 2015), survival at 10, 20 and 30 years after the Fontan operation was 74%, 61% and 43%, respectively. The main causes of death are heart failure, sudden death (arrhythmia), thromboembolism and Fontan-related multiorgan failure. Representative long-term Fontan-related complications include protein-losing enteropathy (PLE, about 5–10%), Fontan-associated liver disease (FALD: liver fibrosis, cirrhosis, hepatocellular carcinoma), pulmonary arteriovenous malformations (PAVM), atrial fibrillation/atrial flutter and thromboembolism. Neurodevelopmental outcomes: neurodevelopmental delay, learning disabilities and impaired executive function may occur in proportion to cardiopulmonary bypass time and the number of operations. Pregnancy is classified as high risk in Fontan patients, and prenatal multidisciplinary counseling is essential. Heart transplantation may be the final option for end-stage Fontan failure.
12. Prevention
There is currently no specific primary prevention for single ventricle/double inlet ventricle, but general prevention of congenital heart malformations through elimination of known risk factors is recommended. Folic acid supplementation (400–800 μg/day) before and in early pregnancy, optimal glycemic control of diabetes (HbA1c <6.5%) and avoidance of fetotoxic drugs (lithium, valproic acid, isotretinoin) contribute to reducing the overall risk of congenital heart malformations. When a single ventricle–related malformation such as HLHS or tricuspid atresia has occurred in the family, prenatal genetic counseling taking the recurrence risk (about 2–4%) into account and detailed fetal echocardiography should be provided. When a known genetic syndrome such as Noonan syndrome, CHARGE syndrome or 22q11.2 deletion is identified, detailed evaluation for associated single ventricle is needed. After a prenatal diagnosis of HLHS/single ventricle, multidisciplinary counseling—pediatric cardiology, genetics, neonatology, congenital cardiac surgery and social work—should be provided to decide whether to continue the pregnancy and the direction of treatment. After diagnosis, a systematic three-stage surgical plan and a system for long-term surveillance of Fontan-related complications are key to optimizing prognosis.
References
- Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240-248. [PMID 5089489]
- Norwood WI, et al. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med. 1983;308(1):23-26. [PMID 6336883]
- de Leval MR, et al. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. J Thorac Cardiovasc Surg. 1988;96(5):682-695. [PMID 3184963]
- Khairy P, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117(1):85-92. [PMID 18071068]
- Pundi KN, et al. 40-year follow-up after the Fontan operation. J Am Coll Cardiol. 2015;66(15):1700-1710. [PMID 26449143]
- Gewillig M, Brown SC. The Fontan circulation after 45 years: update in physiology. Heart. 2016;102(14):1081-1086. [PMID 27001786]
- Anderson RH, et al. Morphological spectrum of double-inlet ventricle. Br Heart J. 1983;50(2):176-181. [PMID 6882171]
- Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900. [PMID 12084585]
- Pierpont ME, et al. Genetic basis for congenital heart disease: revisited. Circulation. 2018;138(21):e653-e711. [PMID 30571578]
- Warnes CA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. 2008;52(23):e143-263. [PMID 19038677]